Global Plasma-derived Medicinal Products Market Research Report 2025(Status and Outlook)
Report Overview
Plasma-derived medicinal products (PDMPs) are industrially manufactured from human plasma by pharmaceutical companies. Plasma is the liquid part of blood and it can be collected through specific procedures called plasmapheresis or obtained by the separation from the other components through physical means (centrifugation). PDMPs play a key, and sometimes non-replaceable, role in the treatment of many acute and chronic clinical conditions.
This report provides a deep insight into the global Plasma-derived Medicinal Products market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Plasma-derived Medicinal Products Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Plasma-derived Medicinal Products market in any manner.
Global Plasma-derived Medicinal Products Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
Shanghai RAAS
China Biologic Products
Hualan Biological Engineering Inc.
Beijing Tiantan Biological Products Corp
Pacific Shuanglin
Boya Bio-Pharmaceutical
Paisi Feike Biology Pharmacy Co.
Ltd.
Xinjiang Deyuan Bioengineering
Sichuan Yuanda Shuyang Pharmaceutical Co.
Ltd.
Shenzhen Weiguang
Shanxi Kangbao
Nanyue Biopharming Corporation Ltd
Market Segmentation (by Type)
Immunoglobulins
Coagulation Factor Concentrates
Other
Market Segmentation (by Application)
Emergency Care
Epidemic Diseasae
Immune System Disorder
Antibody Deficiency
Coagulation Disorder
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Plasma-derived Medicinal Products Market
Overview of the regional outlook of the Plasma-derived Medicinal Products Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Plasma-derived Medicinal Products Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Plasma-derived medicinal products (PDMPs) are industrially manufactured from human plasma by pharmaceutical companies. Plasma is the liquid part of blood and it can be collected through specific procedures called plasmapheresis or obtained by the separation from the other components through physical means (centrifugation). PDMPs play a key, and sometimes non-replaceable, role in the treatment of many acute and chronic clinical conditions.
This report provides a deep insight into the global Plasma-derived Medicinal Products market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Plasma-derived Medicinal Products Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Plasma-derived Medicinal Products market in any manner.
Global Plasma-derived Medicinal Products Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
Shanghai RAAS
China Biologic Products
Hualan Biological Engineering Inc.
Beijing Tiantan Biological Products Corp
Pacific Shuanglin
Boya Bio-Pharmaceutical
Paisi Feike Biology Pharmacy Co.
Ltd.
Xinjiang Deyuan Bioengineering
Sichuan Yuanda Shuyang Pharmaceutical Co.
Ltd.
Shenzhen Weiguang
Shanxi Kangbao
Nanyue Biopharming Corporation Ltd
Market Segmentation (by Type)
Immunoglobulins
Coagulation Factor Concentrates
Other
Market Segmentation (by Application)
Emergency Care
Epidemic Diseasae
Immune System Disorder
Antibody Deficiency
Coagulation Disorder
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Plasma-derived Medicinal Products Market
Overview of the regional outlook of the Plasma-derived Medicinal Products Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Plasma-derived Medicinal Products Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Plasma-derived Medicinal Products
1.2 Key Market Segments
1.2.1 Plasma-derived Medicinal Products Segment by Type
1.2.2 Plasma-derived Medicinal Products Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GLOBAL PLASMA-DERIVED MEDICINAL PRODUCTS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Plasma-derived Medicinal Products Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Plasma-derived Medicinal Products Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GLOBAL PLASMA-DERIVED MEDICINAL PRODUCTS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Plasma-derived Medicinal Products Product Life Cycle
3.3 Global Plasma-derived Medicinal Products Sales by Manufacturers (2020-2025)
3.4 Global Plasma-derived Medicinal Products Revenue Market Share by Manufacturers (2020-2025)
3.5 Plasma-derived Medicinal Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Plasma-derived Medicinal Products Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Plasma-derived Medicinal Products Manufacturing Sites, Area Served, Product Type
3.8 Plasma-derived Medicinal Products Market Competitive Situation and Trends
3.8.1 Plasma-derived Medicinal Products Market Concentration Rate
3.8.2 Global 5 and 10 Largest Plasma-derived Medicinal Products Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PLASMA-DERIVED MEDICINAL PRODUCTS INDUSTRY CHAIN ANALYSIS
4.1 Plasma-derived Medicinal Products Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PLASMA-DERIVED MEDICINAL PRODUCTS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Plasma-derived Medicinal Products Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Plasma-derived Medicinal Products Market
5.7 ESG Ratings of Leading Companies
6 GLOBAL PLASMA-DERIVED MEDICINAL PRODUCTS MARKET BY REGION
6.1 Global Plasma-derived Medicinal Products Market Size by Region
6.1.1 Global Plasma-derived Medicinal Products Market Size by Region
6.1.2 Global Plasma-derived Medicinal Products Market Size Market Share by Region
6.2 Global Plasma-derived Medicinal Products Sales by Region
6.2.1 Global Plasma-derived Medicinal Products Sales by Region
6.2.2 Global Plasma-derived Medicinal Products Sales Market Share by Region
7 NORTH AMERICA MARKET OVERVIEW
7.1 North America Plasma-derived Medicinal Products Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Plasma-derived Medicinal Products Market Size by Type
7.3 North America Plasma-derived Medicinal Products Market Size by Application
8 EUROPE MARKET OVERVIEW
8.1 Europe Plasma-derived Medicinal Products Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Plasma-derived Medicinal Products Market Size by Type
8.3 Europe Plasma-derived Medicinal Products Market Size by Application
9 ASIA-PACIFIC MARKET OVERVIEW
9.1 Asia-Pacific Plasma-derived Medicinal Products Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Plasma-derived Medicinal Products Market Size by Type
9.3 Asia-Pacific Plasma-derived Medicinal Products Market Size by Application
10 SOUTH AMERICA MARKET OVERVIEW
10.1 South America Plasma-derived Medicinal Products Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Plasma-derived Medicinal Products Market Size by Type
10.3 South America Plasma-derived Medicinal Products Market Size by Application
11 MIDDLE EAST AND AFRICA MARKET OVERVIEW
11.1 Middle East and Africa Plasma-derived Medicinal Products Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Plasma-derived Medicinal Products Market Size by Type
11.3 Middle East and Africa Plasma-derived Medicinal Products Market Size by Application
12 PLASMA-DERIVED MEDICINAL PRODUCTS MARKET PRODUCTION BY REGION
12.1 Global Production of Plasma-derived Medicinal Products by Region(2020-2025)
12.2 Global Plasma-derived Medicinal Products Revenue Market Share by Region (2020-2025)
12.3 Global Plasma-derived Medicinal Products Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Plasma-derived Medicinal Products Production
12.4.1 North America Plasma-derived Medicinal Products Production Growth Rate (2020-2025)
12.4.2 North America Plasma-derived Medicinal Products Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Plasma-derived Medicinal Products Production
12.5.1 Europe Plasma-derived Medicinal Products Production Growth Rate (2020-2025)
12.5.2 Europe Plasma-derived Medicinal Products Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Plasma-derived Medicinal Products Production (2020-2025)
12.6.1 Japan Plasma-derived Medicinal Products Production Growth Rate (2020-2025)
12.6.2 Japan Plasma-derived Medicinal Products Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Plasma-derived Medicinal Products Production (2020-2025)
12.7.1 China Plasma-derived Medicinal Products Production Growth Rate (2020-2025)
12.7.2 China Plasma-derived Medicinal Products Production, Revenue, Price and Gross Margin (2020-2025)
13 PLASMA-DERIVED MEDICINAL PRODUCTS MARKET SEGMENTATION BY TYPE
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Plasma-derived Medicinal Products Sales Market Share by Type (2020-2033)
13.3 Global Plasma-derived Medicinal Products Market Size Market Share by Type (2020-2033)
13.4 Global Plasma-derived Medicinal Products Price by Type (2020-2033)
14 PLASMA-DERIVED MEDICINAL PRODUCTS MARKET SEGMENTATION BY APPLICATION
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Plasma-derived Medicinal Products Market Sales by Application (2020-2033)
14.3 Global Plasma-derived Medicinal Products Market Size (M USD) by Application (2020-2033)
14.4 Global Plasma-derived Medicinal Products Sales Growth Rate by Application (2020-2033)
15 KEY COMPANIES PROFILE
15.1 Takeda
15.1.1 Takeda Basic Information
15.1.2 Takeda Plasma-derived Medicinal Products Product Overview
15.1.3 Takeda Plasma-derived Medicinal Products Product Market Performance
15.1.4 Takeda Business Overview
15.1.5 Takeda SWOT Analysis
15.1.6 Takeda Recent Developments
15.2 CSL
15.2.1 CSL Basic Information
15.2.2 CSL Plasma-derived Medicinal Products Product Overview
15.2.3 CSL Plasma-derived Medicinal Products Product Market Performance
15.2.4 CSL Business Overview
15.2.5 CSL SWOT Analysis
15.2.6 CSL Recent Developments
15.3 Grifols
15.3.1 Grifols Basic Information
15.3.2 Grifols Plasma-derived Medicinal Products Product Overview
15.3.3 Grifols Plasma-derived Medicinal Products Product Market Performance
15.3.4 Grifols Business Overview
15.3.5 Grifols SWOT Analysis
15.3.6 Grifols Recent Developments
15.4 Octapharma
15.4.1 Octapharma Basic Information
15.4.2 Octapharma Plasma-derived Medicinal Products Product Overview
15.4.3 Octapharma Plasma-derived Medicinal Products Product Market Performance
15.4.4 Octapharma Business Overview
15.4.5 Octapharma Recent Developments
15.5 Kedrion
15.5.1 Kedrion Basic Information
15.5.2 Kedrion Plasma-derived Medicinal Products Product Overview
15.5.3 Kedrion Plasma-derived Medicinal Products Product Market Performance
15.5.4 Kedrion Business Overview
15.5.5 Kedrion Recent Developments
15.6 LFB Group
15.6.1 LFB Group Basic Information
15.6.2 LFB Group Plasma-derived Medicinal Products Product Overview
15.6.3 LFB Group Plasma-derived Medicinal Products Product Market Performance
15.6.4 LFB Group Business Overview
15.6.5 LFB Group Recent Developments
15.7 Biotest
15.7.1 Biotest Basic Information
15.7.2 Biotest Plasma-derived Medicinal Products Product Overview
15.7.3 Biotest Plasma-derived Medicinal Products Product Market Performance
15.7.4 Biotest Business Overview
15.7.5 Biotest Recent Developments
15.8 BPL
15.8.1 BPL Basic Information
15.8.2 BPL Plasma-derived Medicinal Products Product Overview
15.8.3 BPL Plasma-derived Medicinal Products Product Market Performance
15.8.4 BPL Business Overview
15.8.5 BPL Recent Developments
15.9 Shanghai RAAS
15.9.1 Shanghai RAAS Basic Information
15.9.2 Shanghai RAAS Plasma-derived Medicinal Products Product Overview
15.9.3 Shanghai RAAS Plasma-derived Medicinal Products Product Market Performance
15.9.4 Shanghai RAAS Business Overview
15.9.5 Shanghai RAAS Recent Developments
15.10 China Biologic Products
15.10.1 China Biologic Products Basic Information
15.10.2 China Biologic Products Plasma-derived Medicinal Products Product Overview
15.10.3 China Biologic Products Plasma-derived Medicinal Products Product Market Performance
15.10.4 China Biologic Products Business Overview
15.10.5 China Biologic Products Recent Developments
15.11 Hualan Biological Engineering Inc.
15.11.1 Hualan Biological Engineering Inc. Basic Information
15.11.2 Hualan Biological Engineering Inc. Plasma-derived Medicinal Products Product Overview
15.11.3 Hualan Biological Engineering Inc. Plasma-derived Medicinal Products Product Market Performance
15.11.4 Hualan Biological Engineering Inc. Business Overview
15.11.5 Hualan Biological Engineering Inc. Recent Developments
15.12 Beijing Tiantan Biological Products Corp
15.12.1 Beijing Tiantan Biological Products Corp Basic Information
15.12.2 Beijing Tiantan Biological Products Corp Plasma-derived Medicinal Products Product Overview
15.12.3 Beijing Tiantan Biological Products Corp Plasma-derived Medicinal Products Product Market Performance
15.12.4 Beijing Tiantan Biological Products Corp Business Overview
15.12.5 Beijing Tiantan Biological Products Corp Recent Developments
15.13 Pacific Shuanglin
15.13.1 Pacific Shuanglin Basic Information
15.13.2 Pacific Shuanglin Plasma-derived Medicinal Products Product Overview
15.13.3 Pacific Shuanglin Plasma-derived Medicinal Products Product Market Performance
15.13.4 Pacific Shuanglin Business Overview
15.13.5 Pacific Shuanglin Recent Developments
15.14 Boya Bio-Pharmaceutical
15.14.1 Boya Bio-Pharmaceutical Basic Information
15.14.2 Boya Bio-Pharmaceutical Plasma-derived Medicinal Products Product Overview
15.14.3 Boya Bio-Pharmaceutical Plasma-derived Medicinal Products Product Market Performance
15.14.4 Boya Bio-Pharmaceutical Business Overview
15.14.5 Boya Bio-Pharmaceutical Recent Developments
15.15 Paisi Feike Biology Pharmacy Co.
15.15.1 Paisi Feike Biology Pharmacy Co. Basic Information
15.15.2 Paisi Feike Biology Pharmacy Co. Plasma-derived Medicinal Products Product Overview
15.15.3 Paisi Feike Biology Pharmacy Co. Plasma-derived Medicinal Products Product Market Performance
15.15.4 Paisi Feike Biology Pharmacy Co. Business Overview
15.15.5 Paisi Feike Biology Pharmacy Co. Recent Developments
15.16 Ltd.
15.16.1 Ltd. Basic Information
15.16.2 Ltd. Plasma-derived Medicinal Products Product Overview
15.16.3 Ltd. Plasma-derived Medicinal Products Product Market Performance
15.16.4 Ltd. Business Overview
15.16.5 Ltd. Recent Developments
15.17 Xinjiang Deyuan Bioengineering
15.17.1 Xinjiang Deyuan Bioengineering Basic Information
15.17.2 Xinjiang Deyuan Bioengineering Plasma-derived Medicinal Products Product Overview
15.17.3 Xinjiang Deyuan Bioengineering Plasma-derived Medicinal Products Product Market Performance
15.17.4 Xinjiang Deyuan Bioengineering Business Overview
15.17.5 Xinjiang Deyuan Bioengineering Recent Developments
15.18 Sichuan Yuanda Shuyang Pharmaceutical Co.
15.18.1 Sichuan Yuanda Shuyang Pharmaceutical Co. Basic Information
15.18.2 Sichuan Yuanda Shuyang Pharmaceutical Co. Plasma-derived Medicinal Products Product Overview
15.18.3 Sichuan Yuanda Shuyang Pharmaceutical Co. Plasma-derived Medicinal Products Product Market Performance
15.18.4 Sichuan Yuanda Shuyang Pharmaceutical Co. Business Overview
15.18.5 Sichuan Yuanda Shuyang Pharmaceutical Co. Recent Developments
15.19 Ltd.
15.19.1 Ltd. Basic Information
15.19.2 Ltd. Plasma-derived Medicinal Products Product Overview
15.19.3 Ltd. Plasma-derived Medicinal Products Product Market Performance
15.19.4 Ltd. Business Overview
15.19.5 Ltd. Recent Developments
15.20 Shenzhen Weiguang
15.20.1 Shenzhen Weiguang Basic Information
15.20.2 Shenzhen Weiguang Plasma-derived Medicinal Products Product Overview
15.20.3 Shenzhen Weiguang Plasma-derived Medicinal Products Product Market Performance
15.20.4 Shenzhen Weiguang Business Overview
15.20.5 Shenzhen Weiguang Recent Developments
15.21 Shanxi Kangbao
15.21.1 Shanxi Kangbao Basic Information
15.21.2 Shanxi Kangbao Plasma-derived Medicinal Products Product Overview
15.21.3 Shanxi Kangbao Plasma-derived Medicinal Products Product Market Performance
15.21.4 Shanxi Kangbao Business Overview
15.21.5 Shanxi Kangbao Recent Developments
15.22 Nanyue Biopharming Corporation Ltd
15.22.1 Nanyue Biopharming Corporation Ltd Basic Information
15.22.2 Nanyue Biopharming Corporation Ltd Plasma-derived Medicinal Products Product Overview
15.22.3 Nanyue Biopharming Corporation Ltd Plasma-derived Medicinal Products Product Market Performance
15.22.4 Nanyue Biopharming Corporation Ltd Business Overview
15.22.5 Nanyue Biopharming Corporation Ltd Recent Developments
16 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Plasma-derived Medicinal Products
1.2 Key Market Segments
1.2.1 Plasma-derived Medicinal Products Segment by Type
1.2.2 Plasma-derived Medicinal Products Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GLOBAL PLASMA-DERIVED MEDICINAL PRODUCTS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Plasma-derived Medicinal Products Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Plasma-derived Medicinal Products Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GLOBAL PLASMA-DERIVED MEDICINAL PRODUCTS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Plasma-derived Medicinal Products Product Life Cycle
3.3 Global Plasma-derived Medicinal Products Sales by Manufacturers (2020-2025)
3.4 Global Plasma-derived Medicinal Products Revenue Market Share by Manufacturers (2020-2025)
3.5 Plasma-derived Medicinal Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Plasma-derived Medicinal Products Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Plasma-derived Medicinal Products Manufacturing Sites, Area Served, Product Type
3.8 Plasma-derived Medicinal Products Market Competitive Situation and Trends
3.8.1 Plasma-derived Medicinal Products Market Concentration Rate
3.8.2 Global 5 and 10 Largest Plasma-derived Medicinal Products Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PLASMA-DERIVED MEDICINAL PRODUCTS INDUSTRY CHAIN ANALYSIS
4.1 Plasma-derived Medicinal Products Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PLASMA-DERIVED MEDICINAL PRODUCTS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Plasma-derived Medicinal Products Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Plasma-derived Medicinal Products Market
5.7 ESG Ratings of Leading Companies
6 GLOBAL PLASMA-DERIVED MEDICINAL PRODUCTS MARKET BY REGION
6.1 Global Plasma-derived Medicinal Products Market Size by Region
6.1.1 Global Plasma-derived Medicinal Products Market Size by Region
6.1.2 Global Plasma-derived Medicinal Products Market Size Market Share by Region
6.2 Global Plasma-derived Medicinal Products Sales by Region
6.2.1 Global Plasma-derived Medicinal Products Sales by Region
6.2.2 Global Plasma-derived Medicinal Products Sales Market Share by Region
7 NORTH AMERICA MARKET OVERVIEW
7.1 North America Plasma-derived Medicinal Products Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Plasma-derived Medicinal Products Market Size by Type
7.3 North America Plasma-derived Medicinal Products Market Size by Application
8 EUROPE MARKET OVERVIEW
8.1 Europe Plasma-derived Medicinal Products Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Plasma-derived Medicinal Products Market Size by Type
8.3 Europe Plasma-derived Medicinal Products Market Size by Application
9 ASIA-PACIFIC MARKET OVERVIEW
9.1 Asia-Pacific Plasma-derived Medicinal Products Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Plasma-derived Medicinal Products Market Size by Type
9.3 Asia-Pacific Plasma-derived Medicinal Products Market Size by Application
10 SOUTH AMERICA MARKET OVERVIEW
10.1 South America Plasma-derived Medicinal Products Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Plasma-derived Medicinal Products Market Size by Type
10.3 South America Plasma-derived Medicinal Products Market Size by Application
11 MIDDLE EAST AND AFRICA MARKET OVERVIEW
11.1 Middle East and Africa Plasma-derived Medicinal Products Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Plasma-derived Medicinal Products Market Size by Type
11.3 Middle East and Africa Plasma-derived Medicinal Products Market Size by Application
12 PLASMA-DERIVED MEDICINAL PRODUCTS MARKET PRODUCTION BY REGION
12.1 Global Production of Plasma-derived Medicinal Products by Region(2020-2025)
12.2 Global Plasma-derived Medicinal Products Revenue Market Share by Region (2020-2025)
12.3 Global Plasma-derived Medicinal Products Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Plasma-derived Medicinal Products Production
12.4.1 North America Plasma-derived Medicinal Products Production Growth Rate (2020-2025)
12.4.2 North America Plasma-derived Medicinal Products Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Plasma-derived Medicinal Products Production
12.5.1 Europe Plasma-derived Medicinal Products Production Growth Rate (2020-2025)
12.5.2 Europe Plasma-derived Medicinal Products Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Plasma-derived Medicinal Products Production (2020-2025)
12.6.1 Japan Plasma-derived Medicinal Products Production Growth Rate (2020-2025)
12.6.2 Japan Plasma-derived Medicinal Products Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Plasma-derived Medicinal Products Production (2020-2025)
12.7.1 China Plasma-derived Medicinal Products Production Growth Rate (2020-2025)
12.7.2 China Plasma-derived Medicinal Products Production, Revenue, Price and Gross Margin (2020-2025)
13 PLASMA-DERIVED MEDICINAL PRODUCTS MARKET SEGMENTATION BY TYPE
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Plasma-derived Medicinal Products Sales Market Share by Type (2020-2033)
13.3 Global Plasma-derived Medicinal Products Market Size Market Share by Type (2020-2033)
13.4 Global Plasma-derived Medicinal Products Price by Type (2020-2033)
14 PLASMA-DERIVED MEDICINAL PRODUCTS MARKET SEGMENTATION BY APPLICATION
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Plasma-derived Medicinal Products Market Sales by Application (2020-2033)
14.3 Global Plasma-derived Medicinal Products Market Size (M USD) by Application (2020-2033)
14.4 Global Plasma-derived Medicinal Products Sales Growth Rate by Application (2020-2033)
15 KEY COMPANIES PROFILE
15.1 Takeda
15.1.1 Takeda Basic Information
15.1.2 Takeda Plasma-derived Medicinal Products Product Overview
15.1.3 Takeda Plasma-derived Medicinal Products Product Market Performance
15.1.4 Takeda Business Overview
15.1.5 Takeda SWOT Analysis
15.1.6 Takeda Recent Developments
15.2 CSL
15.2.1 CSL Basic Information
15.2.2 CSL Plasma-derived Medicinal Products Product Overview
15.2.3 CSL Plasma-derived Medicinal Products Product Market Performance
15.2.4 CSL Business Overview
15.2.5 CSL SWOT Analysis
15.2.6 CSL Recent Developments
15.3 Grifols
15.3.1 Grifols Basic Information
15.3.2 Grifols Plasma-derived Medicinal Products Product Overview
15.3.3 Grifols Plasma-derived Medicinal Products Product Market Performance
15.3.4 Grifols Business Overview
15.3.5 Grifols SWOT Analysis
15.3.6 Grifols Recent Developments
15.4 Octapharma
15.4.1 Octapharma Basic Information
15.4.2 Octapharma Plasma-derived Medicinal Products Product Overview
15.4.3 Octapharma Plasma-derived Medicinal Products Product Market Performance
15.4.4 Octapharma Business Overview
15.4.5 Octapharma Recent Developments
15.5 Kedrion
15.5.1 Kedrion Basic Information
15.5.2 Kedrion Plasma-derived Medicinal Products Product Overview
15.5.3 Kedrion Plasma-derived Medicinal Products Product Market Performance
15.5.4 Kedrion Business Overview
15.5.5 Kedrion Recent Developments
15.6 LFB Group
15.6.1 LFB Group Basic Information
15.6.2 LFB Group Plasma-derived Medicinal Products Product Overview
15.6.3 LFB Group Plasma-derived Medicinal Products Product Market Performance
15.6.4 LFB Group Business Overview
15.6.5 LFB Group Recent Developments
15.7 Biotest
15.7.1 Biotest Basic Information
15.7.2 Biotest Plasma-derived Medicinal Products Product Overview
15.7.3 Biotest Plasma-derived Medicinal Products Product Market Performance
15.7.4 Biotest Business Overview
15.7.5 Biotest Recent Developments
15.8 BPL
15.8.1 BPL Basic Information
15.8.2 BPL Plasma-derived Medicinal Products Product Overview
15.8.3 BPL Plasma-derived Medicinal Products Product Market Performance
15.8.4 BPL Business Overview
15.8.5 BPL Recent Developments
15.9 Shanghai RAAS
15.9.1 Shanghai RAAS Basic Information
15.9.2 Shanghai RAAS Plasma-derived Medicinal Products Product Overview
15.9.3 Shanghai RAAS Plasma-derived Medicinal Products Product Market Performance
15.9.4 Shanghai RAAS Business Overview
15.9.5 Shanghai RAAS Recent Developments
15.10 China Biologic Products
15.10.1 China Biologic Products Basic Information
15.10.2 China Biologic Products Plasma-derived Medicinal Products Product Overview
15.10.3 China Biologic Products Plasma-derived Medicinal Products Product Market Performance
15.10.4 China Biologic Products Business Overview
15.10.5 China Biologic Products Recent Developments
15.11 Hualan Biological Engineering Inc.
15.11.1 Hualan Biological Engineering Inc. Basic Information
15.11.2 Hualan Biological Engineering Inc. Plasma-derived Medicinal Products Product Overview
15.11.3 Hualan Biological Engineering Inc. Plasma-derived Medicinal Products Product Market Performance
15.11.4 Hualan Biological Engineering Inc. Business Overview
15.11.5 Hualan Biological Engineering Inc. Recent Developments
15.12 Beijing Tiantan Biological Products Corp
15.12.1 Beijing Tiantan Biological Products Corp Basic Information
15.12.2 Beijing Tiantan Biological Products Corp Plasma-derived Medicinal Products Product Overview
15.12.3 Beijing Tiantan Biological Products Corp Plasma-derived Medicinal Products Product Market Performance
15.12.4 Beijing Tiantan Biological Products Corp Business Overview
15.12.5 Beijing Tiantan Biological Products Corp Recent Developments
15.13 Pacific Shuanglin
15.13.1 Pacific Shuanglin Basic Information
15.13.2 Pacific Shuanglin Plasma-derived Medicinal Products Product Overview
15.13.3 Pacific Shuanglin Plasma-derived Medicinal Products Product Market Performance
15.13.4 Pacific Shuanglin Business Overview
15.13.5 Pacific Shuanglin Recent Developments
15.14 Boya Bio-Pharmaceutical
15.14.1 Boya Bio-Pharmaceutical Basic Information
15.14.2 Boya Bio-Pharmaceutical Plasma-derived Medicinal Products Product Overview
15.14.3 Boya Bio-Pharmaceutical Plasma-derived Medicinal Products Product Market Performance
15.14.4 Boya Bio-Pharmaceutical Business Overview
15.14.5 Boya Bio-Pharmaceutical Recent Developments
15.15 Paisi Feike Biology Pharmacy Co.
15.15.1 Paisi Feike Biology Pharmacy Co. Basic Information
15.15.2 Paisi Feike Biology Pharmacy Co. Plasma-derived Medicinal Products Product Overview
15.15.3 Paisi Feike Biology Pharmacy Co. Plasma-derived Medicinal Products Product Market Performance
15.15.4 Paisi Feike Biology Pharmacy Co. Business Overview
15.15.5 Paisi Feike Biology Pharmacy Co. Recent Developments
15.16 Ltd.
15.16.1 Ltd. Basic Information
15.16.2 Ltd. Plasma-derived Medicinal Products Product Overview
15.16.3 Ltd. Plasma-derived Medicinal Products Product Market Performance
15.16.4 Ltd. Business Overview
15.16.5 Ltd. Recent Developments
15.17 Xinjiang Deyuan Bioengineering
15.17.1 Xinjiang Deyuan Bioengineering Basic Information
15.17.2 Xinjiang Deyuan Bioengineering Plasma-derived Medicinal Products Product Overview
15.17.3 Xinjiang Deyuan Bioengineering Plasma-derived Medicinal Products Product Market Performance
15.17.4 Xinjiang Deyuan Bioengineering Business Overview
15.17.5 Xinjiang Deyuan Bioengineering Recent Developments
15.18 Sichuan Yuanda Shuyang Pharmaceutical Co.
15.18.1 Sichuan Yuanda Shuyang Pharmaceutical Co. Basic Information
15.18.2 Sichuan Yuanda Shuyang Pharmaceutical Co. Plasma-derived Medicinal Products Product Overview
15.18.3 Sichuan Yuanda Shuyang Pharmaceutical Co. Plasma-derived Medicinal Products Product Market Performance
15.18.4 Sichuan Yuanda Shuyang Pharmaceutical Co. Business Overview
15.18.5 Sichuan Yuanda Shuyang Pharmaceutical Co. Recent Developments
15.19 Ltd.
15.19.1 Ltd. Basic Information
15.19.2 Ltd. Plasma-derived Medicinal Products Product Overview
15.19.3 Ltd. Plasma-derived Medicinal Products Product Market Performance
15.19.4 Ltd. Business Overview
15.19.5 Ltd. Recent Developments
15.20 Shenzhen Weiguang
15.20.1 Shenzhen Weiguang Basic Information
15.20.2 Shenzhen Weiguang Plasma-derived Medicinal Products Product Overview
15.20.3 Shenzhen Weiguang Plasma-derived Medicinal Products Product Market Performance
15.20.4 Shenzhen Weiguang Business Overview
15.20.5 Shenzhen Weiguang Recent Developments
15.21 Shanxi Kangbao
15.21.1 Shanxi Kangbao Basic Information
15.21.2 Shanxi Kangbao Plasma-derived Medicinal Products Product Overview
15.21.3 Shanxi Kangbao Plasma-derived Medicinal Products Product Market Performance
15.21.4 Shanxi Kangbao Business Overview
15.21.5 Shanxi Kangbao Recent Developments
15.22 Nanyue Biopharming Corporation Ltd
15.22.1 Nanyue Biopharming Corporation Ltd Basic Information
15.22.2 Nanyue Biopharming Corporation Ltd Plasma-derived Medicinal Products Product Overview
15.22.3 Nanyue Biopharming Corporation Ltd Plasma-derived Medicinal Products Product Market Performance
15.22.4 Nanyue Biopharming Corporation Ltd Business Overview
15.22.5 Nanyue Biopharming Corporation Ltd Recent Developments
16 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Plasma-derived Medicinal Products Market Size by Type (M USD)
Table 4. Global Plasma-derived Medicinal Products Market Size by Application (M USD)
Table 5. Plasma-derived Medicinal Products Market Size Comparison by Region (M USD)
Table 6. Global Plasma-derived Medicinal Products Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Plasma-derived Medicinal Products Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Plasma-derived Medicinal Products Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Plasma-derived Medicinal Products Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma-derived Medicinal Products as of 2024)
Table 11. Global Market Plasma-derived Medicinal Products Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Plasma-derived Medicinal Products Manufacturing Sites and Area Served
Table 13. Manufacturers Plasma-derived Medicinal Products Product Type
Table 14. Global Plasma-derived Medicinal Products Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Plasma-derived Medicinal Products Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Plasma-derived Medicinal Products Market Size Comparison by Region (M USD)
Table 26. Global Plasma-derived Medicinal Products Market Size by Region (2020-2033) & (M USD)
Table 27. Global Plasma-derived Medicinal Products Market Size Market Share by Region (2020-2033)
Table 28. Global Plasma-derived Medicinal Products Sales by Region (2020-2033) & (K MT)
Table 29. Global Plasma-derived Medicinal Products Sales Market Share by Region (2020-2033)
Table 30. North America Plasma-derived Medicinal Products Market Size by Country (2020-2033) & (M USD)
Table 31. North America Plasma-derived Medicinal Products Sales by Country (2020-2033) & (K MT)
Table 32. North America Plasma-derived Medicinal Products Sales by Type (K MT)
Table 33. North America Plasma-derived Medicinal Products Market Size by Type (M USD)
Table 34. North America Plasma-derived Medicinal Products Sales (K MT) by Type (2020-2033)
Table 35. North America Plasma-derived Medicinal Products Market Size (M USD) by Type (2020-2033)
Table 36. North America Plasma-derived Medicinal Products Sales by Application (K MT)
Table 37. North America Plasma-derived Medicinal Products Market Size by Application (M USD)
Table 38. North America Plasma-derived Medicinal Products Sales (K MT) by Application (2020-2033)
Table 39. North America Plasma-derived Medicinal Products Market Size (M USD) by Application (2020-2033)
Table 40. Europe Plasma-derived Medicinal Products Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Plasma-derived Medicinal Products Sales by Country (2020-2033) & (K MT)
Table 42. Europe Plasma-derived Medicinal Products Sales by Type (K MT)
Table 43. Europe Plasma-derived Medicinal Products Market Size by Type (M USD)
Table 44. Europe Plasma-derived Medicinal Products Sales (K MT) by Type (2020-2033)
Table 45. Europe Plasma-derived Medicinal Products Market Size (M USD) by Type (2020-2033)
Table 46. Europe Plasma-derived Medicinal Products Sales by Application (K MT)
Table 47. Europe Plasma-derived Medicinal Products Market Size by Application (M USD)
Table 48. Europe Plasma-derived Medicinal Products Sales (K MT) by Application (2020-2033)
Table 49. Europe Plasma-derived Medicinal Products Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Plasma-derived Medicinal Products Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Plasma-derived Medicinal Products Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Plasma-derived Medicinal Products Sales by Type (K MT)
Table 53. Asia-Pacific Plasma-derived Medicinal Products Market Size by Type (M USD)
Table 54. Asia-Pacific Plasma-derived Medicinal Products Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Plasma-derived Medicinal Products Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Plasma-derived Medicinal Products Sales by Application (K MT)
Table 57. Asia-Pacific Plasma-derived Medicinal Products Market Size by Application (M USD)
Table 58. Asia-Pacific Plasma-derived Medicinal Products Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Plasma-derived Medicinal Products Market Size (M USD) by Application (2020-2025)
Table 60. South America Plasma-derived Medicinal Products Market Size by Country (2020-2033) & (M USD)
Table 61. South America Plasma-derived Medicinal Products Sales by Country (2020-2033) & (K MT)
Table 62. South America Plasma-derived Medicinal Products Sales by Type (K MT)
Table 63. South America Plasma-derived Medicinal Products Market Size by Type (M USD)
Table 64. South America Plasma-derived Medicinal Products Sales (K MT) by Type (2020-2033)
Table 65. South America Plasma-derived Medicinal Products Market Size (M USD) by Type (2020-2033)
Table 66. South America Plasma-derived Medicinal Products Sales by Application (K MT)
Table 67. South America Plasma-derived Medicinal Products Market Size by Application (M USD)
Table 68. South America Plasma-derived Medicinal Products Sales (K MT) by Application (2020-2033)
Table 69. South America Plasma-derived Medicinal Products Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Plasma-derived Medicinal Products Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Plasma-derived Medicinal Products Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Plasma-derived Medicinal Products Sales by Type (K MT)
Table 73. Middle East and Africa Plasma-derived Medicinal Products Market Size by Type (M USD)
Table 74. Middle East and Africa Plasma-derived Medicinal Products Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Plasma-derived Medicinal Products Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Plasma-derived Medicinal Products Sales by Application (K MT)
Table 77. Middle East and Africa Plasma-derived Medicinal Products Market Size by Application (M USD)
Table 78. Middle East and Africa Plasma-derived Medicinal Products Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Plasma-derived Medicinal Products Market Size (M USD) by Application (2020-2033)
Table 80. Global Plasma-derived Medicinal Products Production (K MT) by Region(2020-2025)
Table 81. Global Plasma-derived Medicinal Products Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Plasma-derived Medicinal Products Revenue Market Share by Region (2020-2025)
Table 83. Global Plasma-derived Medicinal Products Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Plasma-derived Medicinal Products Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Plasma-derived Medicinal Products Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Plasma-derived Medicinal Products Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Plasma-derived Medicinal Products Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Plasma-derived Medicinal Products Sales by Type (K MT)
Table 89. Global Plasma-derived Medicinal Products Market Size by Type (M USD)
Table 90. Global Plasma-derived Medicinal Products Sales (K MT) by Type (2020-2033)
Table 91. Global Plasma-derived Medicinal Products Sales Market Share by Type (2020-2033)
Table 92. Global Plasma-derived Medicinal Products Market Size (M USD) by Type (2020-2033)
Table 93. Global Plasma-derived Medicinal Products Market Size Share by Type (2020-2033)
Table 94. Global Plasma-derived Medicinal Products Sales (K MT) by Application
Table 95. Global Plasma-derived Medicinal Products Market Size by Application(M USD)
Table 96. Global Plasma-derived Medicinal Products Sales by Application (2020-2033) & (K MT)
Table 97. Global Plasma-derived Medicinal Products Sales Market Share by Application (2020-2033)
Table 98. Global Plasma-derived Medicinal Products Market Size by Application (2020-2033) & (M USD)
Table 99. Global Plasma-derived Medicinal Products Market Share by Application (2020-2033)
Table 100. Global Plasma-derived Medicinal Products Sales Growth Rate by Application (2020-2033)
Table 101. Takeda Basic Information
Table 102. Takeda Plasma-derived Medicinal Products Product Overview
Table 103. Takeda Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Takeda Business Overview
Table 105. Takeda SWOT Analysis
Table 106. Takeda Recent Developments
Table 107. CSL Basic Information
Table 108. CSL Plasma-derived Medicinal Products Product Overview
Table 109. CSL Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. CSL Business Overview
Table 111. CSL SWOT Analysis
Table 112. CSL Recent Developments
Table 113. Grifols Basic Information
Table 114. Grifols Plasma-derived Medicinal Products Product Overview
Table 115. Grifols Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Grifols Business Overview
Table 117. Grifols SWOT Analysis
Table 118. Grifols Recent Developments
Table 119. Octapharma Basic Information
Table 120. Octapharma Plasma-derived Medicinal Products Product Overview
Table 121. Octapharma Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Octapharma Business Overview
Table 123. Octapharma Recent Developments
Table 124. Kedrion Basic Information
Table 125. Kedrion Plasma-derived Medicinal Products Product Overview
Table 126. Kedrion Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Kedrion Business Overview
Table 128. Kedrion Recent Developments
Table 129. LFB Group Basic Information
Table 130. LFB Group Plasma-derived Medicinal Products Product Overview
Table 131. LFB Group Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. LFB Group Business Overview
Table 133. LFB Group Recent Developments
Table 134. Biotest Basic Information
Table 135. Biotest Plasma-derived Medicinal Products Product Overview
Table 136. Biotest Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Biotest Business Overview
Table 138. Biotest Recent Developments
Table 139. BPL Basic Information
Table 140. BPL Plasma-derived Medicinal Products Product Overview
Table 141. BPL Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. BPL Business Overview
Table 143. BPL Recent Developments
Table 144. Shanghai RAAS Basic Information
Table 145. Shanghai RAAS Plasma-derived Medicinal Products Product Overview
Table 146. Shanghai RAAS Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. Shanghai RAAS Business Overview
Table 148. Shanghai RAAS Recent Developments
Table 149. China Biologic Products Basic Information
Table 150. China Biologic Products Plasma-derived Medicinal Products Product Overview
Table 151. China Biologic Products Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. China Biologic Products Business Overview
Table 153. China Biologic Products Recent Developments
Table 154. Hualan Biological Engineering Inc. Basic Information
Table 155. Hualan Biological Engineering Inc. Plasma-derived Medicinal Products Product Overview
Table 156. Hualan Biological Engineering Inc. Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. Hualan Biological Engineering Inc. Business Overview
Table 158. Hualan Biological Engineering Inc. Recent Developments
Table 159. Beijing Tiantan Biological Products Corp Basic Information
Table 160. Beijing Tiantan Biological Products Corp Plasma-derived Medicinal Products Product Overview
Table 161. Beijing Tiantan Biological Products Corp Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 162. Beijing Tiantan Biological Products Corp Business Overview
Table 163. Beijing Tiantan Biological Products Corp Recent Developments
Table 164. Pacific Shuanglin Basic Information
Table 165. Pacific Shuanglin Plasma-derived Medicinal Products Product Overview
Table 166. Pacific Shuanglin Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 167. Pacific Shuanglin Business Overview
Table 168. Pacific Shuanglin Recent Developments
Table 169. Boya Bio-Pharmaceutical Basic Information
Table 170. Boya Bio-Pharmaceutical Plasma-derived Medicinal Products Product Overview
Table 171. Boya Bio-Pharmaceutical Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 172. Boya Bio-Pharmaceutical Business Overview
Table 173. Boya Bio-Pharmaceutical Recent Developments
Table 174. Paisi Feike Biology Pharmacy Co. Basic Information
Table 175. Paisi Feike Biology Pharmacy Co. Plasma-derived Medicinal Products Product Overview
Table 176. Paisi Feike Biology Pharmacy Co. Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 177. Paisi Feike Biology Pharmacy Co. Business Overview
Table 178. Paisi Feike Biology Pharmacy Co. Recent Developments
Table 179. Ltd. Basic Information
Table 180. Ltd. Plasma-derived Medicinal Products Product Overview
Table 181. Ltd. Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 182. Ltd. Business Overview
Table 183. Ltd. Recent Developments
Table 184. Xinjiang Deyuan Bioengineering Basic Information
Table 185. Xinjiang Deyuan Bioengineering Plasma-derived Medicinal Products Product Overview
Table 186. Xinjiang Deyuan Bioengineering Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 187. Xinjiang Deyuan Bioengineering Business Overview
Table 188. Xinjiang Deyuan Bioengineering Recent Developments
Table 189. Sichuan Yuanda Shuyang Pharmaceutical Co. Basic Information
Table 190. Sichuan Yuanda Shuyang Pharmaceutical Co. Plasma-derived Medicinal Products Product Overview
Table 191. Sichuan Yuanda Shuyang Pharmaceutical Co. Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 192. Sichuan Yuanda Shuyang Pharmaceutical Co. Business Overview
Table 193. Sichuan Yuanda Shuyang Pharmaceutical Co. Recent Developments
Table 194. Ltd. Basic Information
Table 195. Ltd. Plasma-derived Medicinal Products Product Overview
Table 196. Ltd. Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 197. Ltd. Business Overview
Table 198. Ltd. Recent Developments
Table 199. Shenzhen Weiguang Basic Information
Table 200. Shenzhen Weiguang Plasma-derived Medicinal Products Product Overview
Table 201. Shenzhen Weiguang Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 202. Shenzhen Weiguang Business Overview
Table 203. Shenzhen Weiguang Recent Developments
Table 204. Shanxi Kangbao Basic Information
Table 205. Shanxi Kangbao Plasma-derived Medicinal Products Product Overview
Table 206. Shanxi Kangbao Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 207. Shanxi Kangbao Business Overview
Table 208. Shanxi Kangbao Recent Developments
Table 209. Nanyue Biopharming Corporation Ltd Basic Information
Table 210. Nanyue Biopharming Corporation Ltd Plasma-derived Medicinal Products Product Overview
Table 211. Nanyue Biopharming Corporation Ltd Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 212. Nanyue Biopharming Corporation Ltd Business Overview
Table 213. Nanyue Biopharming Corporation Ltd Recent Developments
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Plasma-derived Medicinal Products Market Size by Type (M USD)
Table 4. Global Plasma-derived Medicinal Products Market Size by Application (M USD)
Table 5. Plasma-derived Medicinal Products Market Size Comparison by Region (M USD)
Table 6. Global Plasma-derived Medicinal Products Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Plasma-derived Medicinal Products Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Plasma-derived Medicinal Products Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Plasma-derived Medicinal Products Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma-derived Medicinal Products as of 2024)
Table 11. Global Market Plasma-derived Medicinal Products Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Plasma-derived Medicinal Products Manufacturing Sites and Area Served
Table 13. Manufacturers Plasma-derived Medicinal Products Product Type
Table 14. Global Plasma-derived Medicinal Products Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Plasma-derived Medicinal Products Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Plasma-derived Medicinal Products Market Size Comparison by Region (M USD)
Table 26. Global Plasma-derived Medicinal Products Market Size by Region (2020-2033) & (M USD)
Table 27. Global Plasma-derived Medicinal Products Market Size Market Share by Region (2020-2033)
Table 28. Global Plasma-derived Medicinal Products Sales by Region (2020-2033) & (K MT)
Table 29. Global Plasma-derived Medicinal Products Sales Market Share by Region (2020-2033)
Table 30. North America Plasma-derived Medicinal Products Market Size by Country (2020-2033) & (M USD)
Table 31. North America Plasma-derived Medicinal Products Sales by Country (2020-2033) & (K MT)
Table 32. North America Plasma-derived Medicinal Products Sales by Type (K MT)
Table 33. North America Plasma-derived Medicinal Products Market Size by Type (M USD)
Table 34. North America Plasma-derived Medicinal Products Sales (K MT) by Type (2020-2033)
Table 35. North America Plasma-derived Medicinal Products Market Size (M USD) by Type (2020-2033)
Table 36. North America Plasma-derived Medicinal Products Sales by Application (K MT)
Table 37. North America Plasma-derived Medicinal Products Market Size by Application (M USD)
Table 38. North America Plasma-derived Medicinal Products Sales (K MT) by Application (2020-2033)
Table 39. North America Plasma-derived Medicinal Products Market Size (M USD) by Application (2020-2033)
Table 40. Europe Plasma-derived Medicinal Products Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Plasma-derived Medicinal Products Sales by Country (2020-2033) & (K MT)
Table 42. Europe Plasma-derived Medicinal Products Sales by Type (K MT)
Table 43. Europe Plasma-derived Medicinal Products Market Size by Type (M USD)
Table 44. Europe Plasma-derived Medicinal Products Sales (K MT) by Type (2020-2033)
Table 45. Europe Plasma-derived Medicinal Products Market Size (M USD) by Type (2020-2033)
Table 46. Europe Plasma-derived Medicinal Products Sales by Application (K MT)
Table 47. Europe Plasma-derived Medicinal Products Market Size by Application (M USD)
Table 48. Europe Plasma-derived Medicinal Products Sales (K MT) by Application (2020-2033)
Table 49. Europe Plasma-derived Medicinal Products Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Plasma-derived Medicinal Products Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Plasma-derived Medicinal Products Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Plasma-derived Medicinal Products Sales by Type (K MT)
Table 53. Asia-Pacific Plasma-derived Medicinal Products Market Size by Type (M USD)
Table 54. Asia-Pacific Plasma-derived Medicinal Products Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Plasma-derived Medicinal Products Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Plasma-derived Medicinal Products Sales by Application (K MT)
Table 57. Asia-Pacific Plasma-derived Medicinal Products Market Size by Application (M USD)
Table 58. Asia-Pacific Plasma-derived Medicinal Products Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Plasma-derived Medicinal Products Market Size (M USD) by Application (2020-2025)
Table 60. South America Plasma-derived Medicinal Products Market Size by Country (2020-2033) & (M USD)
Table 61. South America Plasma-derived Medicinal Products Sales by Country (2020-2033) & (K MT)
Table 62. South America Plasma-derived Medicinal Products Sales by Type (K MT)
Table 63. South America Plasma-derived Medicinal Products Market Size by Type (M USD)
Table 64. South America Plasma-derived Medicinal Products Sales (K MT) by Type (2020-2033)
Table 65. South America Plasma-derived Medicinal Products Market Size (M USD) by Type (2020-2033)
Table 66. South America Plasma-derived Medicinal Products Sales by Application (K MT)
Table 67. South America Plasma-derived Medicinal Products Market Size by Application (M USD)
Table 68. South America Plasma-derived Medicinal Products Sales (K MT) by Application (2020-2033)
Table 69. South America Plasma-derived Medicinal Products Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Plasma-derived Medicinal Products Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Plasma-derived Medicinal Products Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Plasma-derived Medicinal Products Sales by Type (K MT)
Table 73. Middle East and Africa Plasma-derived Medicinal Products Market Size by Type (M USD)
Table 74. Middle East and Africa Plasma-derived Medicinal Products Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Plasma-derived Medicinal Products Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Plasma-derived Medicinal Products Sales by Application (K MT)
Table 77. Middle East and Africa Plasma-derived Medicinal Products Market Size by Application (M USD)
Table 78. Middle East and Africa Plasma-derived Medicinal Products Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Plasma-derived Medicinal Products Market Size (M USD) by Application (2020-2033)
Table 80. Global Plasma-derived Medicinal Products Production (K MT) by Region(2020-2025)
Table 81. Global Plasma-derived Medicinal Products Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Plasma-derived Medicinal Products Revenue Market Share by Region (2020-2025)
Table 83. Global Plasma-derived Medicinal Products Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Plasma-derived Medicinal Products Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Plasma-derived Medicinal Products Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Plasma-derived Medicinal Products Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Plasma-derived Medicinal Products Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Plasma-derived Medicinal Products Sales by Type (K MT)
Table 89. Global Plasma-derived Medicinal Products Market Size by Type (M USD)
Table 90. Global Plasma-derived Medicinal Products Sales (K MT) by Type (2020-2033)
Table 91. Global Plasma-derived Medicinal Products Sales Market Share by Type (2020-2033)
Table 92. Global Plasma-derived Medicinal Products Market Size (M USD) by Type (2020-2033)
Table 93. Global Plasma-derived Medicinal Products Market Size Share by Type (2020-2033)
Table 94. Global Plasma-derived Medicinal Products Sales (K MT) by Application
Table 95. Global Plasma-derived Medicinal Products Market Size by Application(M USD)
Table 96. Global Plasma-derived Medicinal Products Sales by Application (2020-2033) & (K MT)
Table 97. Global Plasma-derived Medicinal Products Sales Market Share by Application (2020-2033)
Table 98. Global Plasma-derived Medicinal Products Market Size by Application (2020-2033) & (M USD)
Table 99. Global Plasma-derived Medicinal Products Market Share by Application (2020-2033)
Table 100. Global Plasma-derived Medicinal Products Sales Growth Rate by Application (2020-2033)
Table 101. Takeda Basic Information
Table 102. Takeda Plasma-derived Medicinal Products Product Overview
Table 103. Takeda Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Takeda Business Overview
Table 105. Takeda SWOT Analysis
Table 106. Takeda Recent Developments
Table 107. CSL Basic Information
Table 108. CSL Plasma-derived Medicinal Products Product Overview
Table 109. CSL Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. CSL Business Overview
Table 111. CSL SWOT Analysis
Table 112. CSL Recent Developments
Table 113. Grifols Basic Information
Table 114. Grifols Plasma-derived Medicinal Products Product Overview
Table 115. Grifols Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Grifols Business Overview
Table 117. Grifols SWOT Analysis
Table 118. Grifols Recent Developments
Table 119. Octapharma Basic Information
Table 120. Octapharma Plasma-derived Medicinal Products Product Overview
Table 121. Octapharma Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Octapharma Business Overview
Table 123. Octapharma Recent Developments
Table 124. Kedrion Basic Information
Table 125. Kedrion Plasma-derived Medicinal Products Product Overview
Table 126. Kedrion Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Kedrion Business Overview
Table 128. Kedrion Recent Developments
Table 129. LFB Group Basic Information
Table 130. LFB Group Plasma-derived Medicinal Products Product Overview
Table 131. LFB Group Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. LFB Group Business Overview
Table 133. LFB Group Recent Developments
Table 134. Biotest Basic Information
Table 135. Biotest Plasma-derived Medicinal Products Product Overview
Table 136. Biotest Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Biotest Business Overview
Table 138. Biotest Recent Developments
Table 139. BPL Basic Information
Table 140. BPL Plasma-derived Medicinal Products Product Overview
Table 141. BPL Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. BPL Business Overview
Table 143. BPL Recent Developments
Table 144. Shanghai RAAS Basic Information
Table 145. Shanghai RAAS Plasma-derived Medicinal Products Product Overview
Table 146. Shanghai RAAS Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. Shanghai RAAS Business Overview
Table 148. Shanghai RAAS Recent Developments
Table 149. China Biologic Products Basic Information
Table 150. China Biologic Products Plasma-derived Medicinal Products Product Overview
Table 151. China Biologic Products Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. China Biologic Products Business Overview
Table 153. China Biologic Products Recent Developments
Table 154. Hualan Biological Engineering Inc. Basic Information
Table 155. Hualan Biological Engineering Inc. Plasma-derived Medicinal Products Product Overview
Table 156. Hualan Biological Engineering Inc. Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. Hualan Biological Engineering Inc. Business Overview
Table 158. Hualan Biological Engineering Inc. Recent Developments
Table 159. Beijing Tiantan Biological Products Corp Basic Information
Table 160. Beijing Tiantan Biological Products Corp Plasma-derived Medicinal Products Product Overview
Table 161. Beijing Tiantan Biological Products Corp Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 162. Beijing Tiantan Biological Products Corp Business Overview
Table 163. Beijing Tiantan Biological Products Corp Recent Developments
Table 164. Pacific Shuanglin Basic Information
Table 165. Pacific Shuanglin Plasma-derived Medicinal Products Product Overview
Table 166. Pacific Shuanglin Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 167. Pacific Shuanglin Business Overview
Table 168. Pacific Shuanglin Recent Developments
Table 169. Boya Bio-Pharmaceutical Basic Information
Table 170. Boya Bio-Pharmaceutical Plasma-derived Medicinal Products Product Overview
Table 171. Boya Bio-Pharmaceutical Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 172. Boya Bio-Pharmaceutical Business Overview
Table 173. Boya Bio-Pharmaceutical Recent Developments
Table 174. Paisi Feike Biology Pharmacy Co. Basic Information
Table 175. Paisi Feike Biology Pharmacy Co. Plasma-derived Medicinal Products Product Overview
Table 176. Paisi Feike Biology Pharmacy Co. Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 177. Paisi Feike Biology Pharmacy Co. Business Overview
Table 178. Paisi Feike Biology Pharmacy Co. Recent Developments
Table 179. Ltd. Basic Information
Table 180. Ltd. Plasma-derived Medicinal Products Product Overview
Table 181. Ltd. Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 182. Ltd. Business Overview
Table 183. Ltd. Recent Developments
Table 184. Xinjiang Deyuan Bioengineering Basic Information
Table 185. Xinjiang Deyuan Bioengineering Plasma-derived Medicinal Products Product Overview
Table 186. Xinjiang Deyuan Bioengineering Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 187. Xinjiang Deyuan Bioengineering Business Overview
Table 188. Xinjiang Deyuan Bioengineering Recent Developments
Table 189. Sichuan Yuanda Shuyang Pharmaceutical Co. Basic Information
Table 190. Sichuan Yuanda Shuyang Pharmaceutical Co. Plasma-derived Medicinal Products Product Overview
Table 191. Sichuan Yuanda Shuyang Pharmaceutical Co. Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 192. Sichuan Yuanda Shuyang Pharmaceutical Co. Business Overview
Table 193. Sichuan Yuanda Shuyang Pharmaceutical Co. Recent Developments
Table 194. Ltd. Basic Information
Table 195. Ltd. Plasma-derived Medicinal Products Product Overview
Table 196. Ltd. Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 197. Ltd. Business Overview
Table 198. Ltd. Recent Developments
Table 199. Shenzhen Weiguang Basic Information
Table 200. Shenzhen Weiguang Plasma-derived Medicinal Products Product Overview
Table 201. Shenzhen Weiguang Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 202. Shenzhen Weiguang Business Overview
Table 203. Shenzhen Weiguang Recent Developments
Table 204. Shanxi Kangbao Basic Information
Table 205. Shanxi Kangbao Plasma-derived Medicinal Products Product Overview
Table 206. Shanxi Kangbao Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 207. Shanxi Kangbao Business Overview
Table 208. Shanxi Kangbao Recent Developments
Table 209. Nanyue Biopharming Corporation Ltd Basic Information
Table 210. Nanyue Biopharming Corporation Ltd Plasma-derived Medicinal Products Product Overview
Table 211. Nanyue Biopharming Corporation Ltd Plasma-derived Medicinal Products Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 212. Nanyue Biopharming Corporation Ltd Business Overview
Table 213. Nanyue Biopharming Corporation Ltd Recent Developments
LIST OF FIGURES
Figure 1. Product Picture of Plasma-derived Medicinal Products
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Plasma-derived Medicinal Products Market Size (M USD), 2024-2033
Figure 5. Global Plasma-derived Medicinal Products Market Size (M USD) (2020-2033)
Figure 6. Global Plasma-derived Medicinal Products Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Plasma-derived Medicinal Products Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Plasma-derived Medicinal Products Product Life Cycle
Figure 13. Plasma-derived Medicinal Products Sales Share by Manufacturers in 2024
Figure 14. Global Plasma-derived Medicinal Products Revenue Share by Manufacturers in 2024
Figure 15. Plasma-derived Medicinal Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Plasma-derived Medicinal Products Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Plasma-derived Medicinal Products Revenue in 2024
Figure 18. Industry Chain Map of Plasma-derived Medicinal Products
Figure 19. Global Plasma-derived Medicinal Products Market PEST Analysis
Figure 20. Global Plasma-derived Medicinal Products Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Plasma-derived Medicinal Products Market Size by Region
Figure 27. Global Plasma-derived Medicinal Products Market Size Market Share by Region (2020-2033)
Figure 28. Global Plasma-derived Medicinal Products Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Plasma-derived Medicinal Products Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Plasma-derived Medicinal Products Market Size (M USD) by Country
Figure 33. USA Plasma-derived Medicinal Products Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Plasma-derived Medicinal Products Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Plasma-derived Medicinal Products Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Plasma-derived Medicinal Products Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Plasma-derived Medicinal Products Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Plasma-derived Medicinal Products Market Size (M USD)by Type
Figure 40. North America Plasma-derived Medicinal Products Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Plasma-derived Medicinal Products Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Plasma-derived Medicinal Products Market Size (M USD) by Country
Figure 45. Germany Plasma-derived Medicinal Products Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Plasma-derived Medicinal Products Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Plasma-derived Medicinal Products Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Plasma-derived Medicinal Products Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Plasma-derived Medicinal Products Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Plasma-derived Medicinal Products Market Size (M USD) by Type
Figure 56. Europe Plasma-derived Medicinal Products Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Plasma-derived Medicinal Products Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Plasma-derived Medicinal Products Market Size (M USD) by Country
Figure 61. China Plasma-derived Medicinal Products Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Plasma-derived Medicinal Products Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Plasma-derived Medicinal Products Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Plasma-derived Medicinal Products Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Plasma-derived Medicinal Products Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Plasma-derived Medicinal Products Market Size (M USD) by Type
Figure 72. Asia-Pacific Plasma-derived Medicinal Products Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Plasma-derived Medicinal Products Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Plasma-derived Medicinal Products Market Size (M USD) by Country
Figure 77. Brazil Plasma-derived Medicinal Products Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Plasma-derived Medicinal Products Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Plasma-derived Medicinal Products Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Plasma-derived Medicinal Products Market Size (M USD) by Type
Figure 84. South America Plasma-derived Medicinal Products Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Plasma-derived Medicinal Products Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Plasma-derived Medicinal Products Market Size (M USD) by Country
Figure 89. Saudi Arabia Plasma-derived Medicinal Products Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Plasma-derived Medicinal Products Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Plasma-derived Medicinal Products Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Plasma-derived Medicinal Products Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Plasma-derived Medicinal Products Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Plasma-derived Medicinal Products Market Size (M USD) by Type
Figure 100. Middle East and Africa Plasma-derived Medicinal Products Market Size (M USD) by Application
Figure 101. Global Plasma-derived Medicinal Products Production Market Share by Region (2020-2025)
Figure 102. North America Plasma-derived Medicinal Products Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Plasma-derived Medicinal Products Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Plasma-derived Medicinal Products Production (K MT) Growth Rate (2020-2025)
Figure 105. China Plasma-derived Medicinal Products Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Plasma-derived Medicinal Products Market Size by Type (M USD)
Figure 108. Sales Market Share of Plasma-derived Medicinal Products by Type (2020-2033)
Figure 109. Sales Market Share of Plasma-derived Medicinal Products by Type in 2024
Figure 110. Market Size Share of Plasma-derived Medicinal Products by Type (2020-2033)
Figure 111. Market Size Share of Plasma-derived Medicinal Products by Type in 2024
Figure 112. Global Plasma-derived Medicinal Products Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Plasma-derived Medicinal Products Market Size by Application(M USD)
Figure 115. Global Plasma-derived Medicinal Products Market Share by Application
Figure 116. Global Plasma-derived Medicinal Products Sales Market Share by Application (2020-2033)
Figure 117. Global Plasma-derived Medicinal Products Sales Market Share by Application in 2024
Figure 118. Global Plasma-derived Medicinal Products Market Share by Application (2020-2033)
Figure 119. Global Plasma-derived Medicinal Products Market Share by Application in 2024
Figure 120. Global Plasma-derived Medicinal Products Sales Growth Rate by Application (2020-2033)
Figure 1. Product Picture of Plasma-derived Medicinal Products
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Plasma-derived Medicinal Products Market Size (M USD), 2024-2033
Figure 5. Global Plasma-derived Medicinal Products Market Size (M USD) (2020-2033)
Figure 6. Global Plasma-derived Medicinal Products Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Plasma-derived Medicinal Products Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Plasma-derived Medicinal Products Product Life Cycle
Figure 13. Plasma-derived Medicinal Products Sales Share by Manufacturers in 2024
Figure 14. Global Plasma-derived Medicinal Products Revenue Share by Manufacturers in 2024
Figure 15. Plasma-derived Medicinal Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Plasma-derived Medicinal Products Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Plasma-derived Medicinal Products Revenue in 2024
Figure 18. Industry Chain Map of Plasma-derived Medicinal Products
Figure 19. Global Plasma-derived Medicinal Products Market PEST Analysis
Figure 20. Global Plasma-derived Medicinal Products Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Plasma-derived Medicinal Products Market Size by Region
Figure 27. Global Plasma-derived Medicinal Products Market Size Market Share by Region (2020-2033)
Figure 28. Global Plasma-derived Medicinal Products Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Plasma-derived Medicinal Products Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Plasma-derived Medicinal Products Market Size (M USD) by Country
Figure 33. USA Plasma-derived Medicinal Products Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Plasma-derived Medicinal Products Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Plasma-derived Medicinal Products Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Plasma-derived Medicinal Products Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Plasma-derived Medicinal Products Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Plasma-derived Medicinal Products Market Size (M USD)by Type
Figure 40. North America Plasma-derived Medicinal Products Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Plasma-derived Medicinal Products Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Plasma-derived Medicinal Products Market Size (M USD) by Country
Figure 45. Germany Plasma-derived Medicinal Products Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Plasma-derived Medicinal Products Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Plasma-derived Medicinal Products Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Plasma-derived Medicinal Products Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Plasma-derived Medicinal Products Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Plasma-derived Medicinal Products Market Size (M USD) by Type
Figure 56. Europe Plasma-derived Medicinal Products Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Plasma-derived Medicinal Products Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Plasma-derived Medicinal Products Market Size (M USD) by Country
Figure 61. China Plasma-derived Medicinal Products Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Plasma-derived Medicinal Products Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Plasma-derived Medicinal Products Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Plasma-derived Medicinal Products Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Plasma-derived Medicinal Products Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Plasma-derived Medicinal Products Market Size (M USD) by Type
Figure 72. Asia-Pacific Plasma-derived Medicinal Products Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Plasma-derived Medicinal Products Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Plasma-derived Medicinal Products Market Size (M USD) by Country
Figure 77. Brazil Plasma-derived Medicinal Products Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Plasma-derived Medicinal Products Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Plasma-derived Medicinal Products Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Plasma-derived Medicinal Products Market Size (M USD) by Type
Figure 84. South America Plasma-derived Medicinal Products Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Plasma-derived Medicinal Products Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Plasma-derived Medicinal Products Market Size (M USD) by Country
Figure 89. Saudi Arabia Plasma-derived Medicinal Products Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Plasma-derived Medicinal Products Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Plasma-derived Medicinal Products Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Plasma-derived Medicinal Products Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Plasma-derived Medicinal Products Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Plasma-derived Medicinal Products Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Plasma-derived Medicinal Products Market Size (M USD) by Type
Figure 100. Middle East and Africa Plasma-derived Medicinal Products Market Size (M USD) by Application
Figure 101. Global Plasma-derived Medicinal Products Production Market Share by Region (2020-2025)
Figure 102. North America Plasma-derived Medicinal Products Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Plasma-derived Medicinal Products Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Plasma-derived Medicinal Products Production (K MT) Growth Rate (2020-2025)
Figure 105. China Plasma-derived Medicinal Products Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Plasma-derived Medicinal Products Market Size by Type (M USD)
Figure 108. Sales Market Share of Plasma-derived Medicinal Products by Type (2020-2033)
Figure 109. Sales Market Share of Plasma-derived Medicinal Products by Type in 2024
Figure 110. Market Size Share of Plasma-derived Medicinal Products by Type (2020-2033)
Figure 111. Market Size Share of Plasma-derived Medicinal Products by Type in 2024
Figure 112. Global Plasma-derived Medicinal Products Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Plasma-derived Medicinal Products Market Size by Application(M USD)
Figure 115. Global Plasma-derived Medicinal Products Market Share by Application
Figure 116. Global Plasma-derived Medicinal Products Sales Market Share by Application (2020-2033)
Figure 117. Global Plasma-derived Medicinal Products Sales Market Share by Application in 2024
Figure 118. Global Plasma-derived Medicinal Products Market Share by Application (2020-2033)
Figure 119. Global Plasma-derived Medicinal Products Market Share by Application in 2024
Figure 120. Global Plasma-derived Medicinal Products Sales Growth Rate by Application (2020-2033)
